Prevalence and Susceptibility of Staphylococcus aureus Nasal Carriage Strains Isolated from Haemodialysis Patients
Main Article Content
Abstract
Introduction: Staphylococcus aureus is part of the normal human flora that can commonly be found on the skin and mucous membranes of the nasal area. However, in immunosuppressed patients such as those with kidney failures, colonization can potentially lead to infection. There is a concern of increasing antibiotic resistance in S. aureus. This study aimed to determine the prevalence of S. aureus nasal colonization and its antimicrobial susceptibility among haemodialysis-dependent populations. Methods: A cross-sectional study at the Nephrology Unit, Hospital Cansel- ori Tuanku Mukhriz (HCTM) was conducted among haemodialysis-dependent patients between February 2017 to February 2018. Nasal swabs were obtained and cultured on mannitol salt agar. S. aureus isolates were identified by gram staining, tube coagulase and Deoxyribonuclease (DNase). Cefoxitin disc (30 µg) were used to identified the presence of MRSA (methicillin-resistance S. aureus). The S. aureus colonies were further tested against six antibiotics using Kirby Bauer disc diffusion. Result: A total of 134 patients were recruited. S. aureus isolates were detected from 27 patients (20.1%). All S. aureus were phenotypically identified as methicillin-sensitive S. aureus (MSSA) based on the cefoxitin disc. Teicoplanin and linezolid were the most effective with 100% susceptibility. S. aureus exhibited a high resistance rate towards erythromycin (29.6%). No MRSA was isolated in this study. Conclusion: This study highlighted the high prevalence of S. aureus nasal colonization in haemodialysis patients. Teicoplanin and linezolid were found to be the most effective antibiotics against isolated S. aureus.
Downloads
Article Details
References
Sakr A, Brégeon F, Mége JL, Rolain JM, Blin O. Staphylococcus aureus Nasal Colonization: An Update on Mechanisms, Epidemiology, Risk Factors, and Subsequent Infections. Front Microbiol. 2018 Oct 8; 9: 2419. doi: 10.3389/ fmicb.2018.02419.
Hanssen AM, Kindlund B, Stenklev NC, et al. Localization of Staphylococcus aureus in tissue from the nasal vestibule in healthy carriers. BMC Microbiol. 2017 April 5;17(1):89. doi:10.1186/ s12866-017-0997-3.
Baur S, Rautenberg M, Faulstich M, et al. A nasal epithelial receptor for Staphylococcus aureus WTA governs adhesion to epithelial cells and modulates nasal colonization. PLoS Patho. 2014;1;10(5): e1004089. doi:10.1371/journal.ppat.1004089.
Vivekananda J, Salgado C, Millenbaugh NJ. DNA aptamers as a novel approach to neutralize Staphylococcus aureus α-toxin. Biochemical and Biophysical Research Communications. 2014;14;444(3):433-8. https://doi: 10.1016/j. bbrc.2014.01.076.
Yoong P, Torres VJ. The effects of Staphylococcus aureus leukotoxins on the host: cell lysis and beyond. Current Microbiol. 2013;1;16(1):63-9. doi: 10.1016/j.mib.2013.01.012.
Jacobsson G, Nasic S. Long-term outcome of invasive Staphylococcus aureus infections. Scandinavian Journal of Infectious Diseases. 2012;1;44(5):350-4. doi: 10.3109/00365548.2011.641504.
Lewis K. Persister cells. Annual Review of Microbiology. 2010;13; 64:357-72. doi:org/10.1146/annurev.micro.112408.134306.
Kim NH, Kang YM, Han WD, et al. Small- colony variants in persistent and recurrent Staphylococcus aureus bacteremia. Microbial Drug Resistance. 2016;1;22(7):538-44. doi: 10.1089/mdr.2015.0262.
Kourtis AP, Hatfield K, Baggs J, et al. Vital signs: epidemiology and recent trends in methicillin- resistant and in methicillin-susceptible Staphylococcus aureus bloodstream infections United States. Morbidity and Mortality Weekly Report. 2019;8;68(9):214-9. doi:10.15585/mmwr.mm6809e1.
European Centre for Disease Prevention and Control. Surveillance of antimicrobial resistance in Europe 2018. [Internet]. Stockholm: ECDC. 2019. Available from: https://www.ecdc.europa. eu/sites/default/files/documents/surveillance- antimicrobial-resistance-Europe-2018.pdf
Ahmad N, Hashim R, Amran F, Zamri H, Liow Y, Abd Rashid F. National Antibiotic Resistance Surveillance Report. [Internet]. Imr.gov.my. 2018. Available from: http://www.imr.gov.my/ images/uploads/NSAR/2018/260619-NATIONAL- ANTIBIOTIC-RESISTANCE-SURVEILLANCE- REPORT-2018-1.pdf
Goh BL, Wong HS. 24th Report of the Malaysian Dialysis and Transplantation Registry. The National Renal Registry. 2018;30-33.
Price A, Sarween N, Gupta I, Baharani J. Meticillin- resistant Staphylococcus aureus and meticillin- susceptible Staphylococcus aureus screening in a cohort of haemodialysis patients: carriage, demographics and outcomes. Journal of Hospital Infection. 2015;1;90(1):22-7. doi:10.1016/j. jhin.2015.01.001.
Grünewald T, Lindner M, Weiß S, et al. Staphylococcus colonization, mortality and morbidity in hemodialysis patients: 10 years of observation. International Journal of Hygiene and Environmental Health. 2013;1;216(6):751-4. doi: 10.1016/j.ijheh.2013.02.005.
Parker MG, Doebbeling BN. The challenge of methicillin-resistant Staphylococcus aureus prevention in hemodialysis therapy. In Seminars in Dialysis. 2012; Jan 25(1):42-49. Oxford, UK: Blackwell Publishing Ltd. doi: 10.1111/j.1525- 139X.2011.00999x.
Lai CF, Liao CH, Pai MF, et al. Nasal carriage of methicillin-resistant Staphylococcus aureus is associated with higher all-cause mortality in hemodialysis patients. Clinical Journal of the American Society of Nephrology. 2011;1;6(1):167-74. doi:10.2215/CJN.06270710.
Gandra S, Barter DM, Laxminarayan R. Economic burden of antibiotic resistance: how much do we really know?. Clinical Microbiology and Infection. 2014;1;20(10):973-80. doi.org/10.1111/1469-0691.12798
Iyer A, Kumosani T, Azhar E, Barbour E, Harakeh S. High incidence rate of methicillin-resistant Staphylococcus aureus (MRSA) among healthcare workers in Saudi Arabia. The Journal of Infection in Developing Countries. 2014;13;8(03):372-8. doi: 10.3855/jidc.3589.
CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 27th ed. CSLI supplement M100. Wayne, PA: Clinical and Laboratory Standards Institute. 2017.
Hidalgo M, Carvajal LP, Rincón S, et al. Methicillin- resistant Staphylococcus aureus USA300 Latin American variant in patients undergoing hemodialysis and HIV infected in a hospital in Bogotá, Colombia. PloS one. 2015;16;10(10): e0140748. doi:10.1371/journal.pone.0140748.
Oumokhtar B, Elazhari M, Timinouni M, et al. Staphylococcus aureus nasal carriage in a Moroccan dialysis center and isolates characterization. Hemodialysis International. 2013;17(4):542-7. doi: 10.1111/j.1542-4758.2012.00759.x.
Ghasemian R, Najafi N, Makhlough A, Khademloo M. Frequency of Nasal Carriage of Staphylococcus aureus and Its Antimicrobial Resistance Pattern in Patients on Hemodialysis. Iranian journal of kidney diseases. 22010;4(3):218-22. PMID: 20622310.
Sapri HF, Sani NA, Noordin A, Neoh H, Hussin S. Virulence gene typing of Methicillin-susceptible Staphylococcus aureus (MSSA) isolates in Universiti Kebangsaan Malaysia Medical Centre (UKMMC). Asia-Pacific Journal of Molecular Medicine. 2011; 1:4.
Horváth, A., Dobay, O., Sahin-Tóth, J. et al. Characterisation of antibiotic resistance, virulence, clonality and mortality in MRSA and MSSA bloodstream infections at a tertiary-level hospital in Hungary: a 6-year retrospective study. Ann Clin Microbiol Antimicrob 19, 17 (2020). doi: 10.1186/ s12941-020-00357-z.
Alfizah H, Norazah A, Nordiah AJ, Lim VK. DNA fingerprinting of methicillin-resistant Staphylococcus aureus (MRSA) by pulsed-field gel electrophoresis (PFGE) in a teaching hospital in Malaysia. Medical Journal of Malaysia. 2002;1;57(3):319-28. PMID: 12440272.
Noordin A, Sapri HF, Sani NA, et al. Antimicrobial resistance profiling and molecular typing of methicillin-resistant Staphylococcus aureus isolated from a Malaysian teaching hospital. Journal of Medical Microbiology. 2016;16;65(12):1476-81. doi:10.1099/jmm.0.000387.
Muttaqillah NA, Hussin S, Neoh H, Noordin A. Clonal diversity of methicillin-resistant Staphylococcus aureus in UKM Medical Centre: characterisation by multilocus sequence typing of different SCCmec type representatives. Sains Malaysiana. 2015;1;44(9):1315-23.
Faber J, Fonseca LM. How sample size influences research outcomes. Dental Press Journal of Orthodontics. 2014;19(4), 27-29. doi: 10.1590/2176-9451.19.4.027-029.ebo
Chen X, Wang WK, Han LZ, et al. Epidemiological and genetic diversity of Staphylococcus aureus causing bloodstream infection in Shanghai, 2009-2011. PLoS One. 2013;9;8(9): e72811. doi.org/10.1371/journal.pone.0072811.
Hasani A, Sheikhalizadeh V, Hasani A, Naghili B, Valizadeh V, Nikoonijad AR. Methicillin resistant and susceptible Staphylococcus aureus: Appraising therapeutic approaches in the Northwest of Iran. Iranian Journal of Microbiology. 2013;5(1):56-62. PMID: 23467268; PMCID: PMC3577566.
Liu Y, Xu Z, Yang Z, Sun J, Ma L. Characterization of community-associated Staphylococcus aureus from skin and soft-tissue infections: a multicenter study in China. Emerging Microbes & Infections. 2016;1;5(1):1-1. doi: 10.1038/emi.2016.128.
Yilmaz ES, Aslantaş Ö. Antimicrobial resistance and underlying mechanisms in Staphylococcus aureus isolates. Asian Pacific Journal of Tropical Medicine. 2017;10(11), 1059-1064. doi:10.1016/j. apjtm.2017.10.003.
Timsina R, Shrestha U, Singh A, Timalsina B. Inducible clindamycin resistance and erm genes in Staphylococcus aureus in school children in Kathmandu, Nepal. Future Science OA 2020; 20;7(1):FSO361. doi: 10.2144/fsoa-2020-0092.
Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. P & T: a peer-reviewed journal for formulary management. 2015;40(4), 277–283. PMID: 25859123; PMCID: PMC4378521.
Van Hal SJ & Fowler VG. Is it time to replace vancomycin in the treatment of methicillin- resistant Staphylococcus aureus infections. Clinical Infectious Disease. 2013. doi: 10.1093/cid/cit178.
Richard HD. Vancomycin: Parental dosing, monitoring, and adverse effects in adults. https://www.uptodate.com/contents/vancomycin- parenteral-dosing-monitoring-and-adverse-effects- in-adults. 2021.
Stokes MB. Vancomycin in the kidney-a novel cast nephropathy. Journal of the American Society of Nephrology: JASN, 28(6), 1669-1670. 2017. doi: 10.1681/ASN.2017010091.
Barceló-Vidal J, Rodriguez GE, Grau S. Extremely high levels of vancomycin can cause severe renal toxicity. Infect Drug Resist. 11:1027-1030. 2018. doi: 10.2147/IDR.S171669.